Search

Search Constraints

You searched for: Author/Creator Merimsky, Ofer

Search Results

1. ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data. (28th January 2022)

2. Cancer Therapeutics–related Cardiac Dysfunction in Patients Treated With Immune Checkpoint Inhibitors: An Understudied Manifestation. Issue 5 (11th June 2021)

3. Cancer Therapeutics–related Cardiac Dysfunction in Patients Treated With Immune Checkpoint Inhibitors: An Understudied Manifestation. Issue 5 (June 2021)

4. Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data. (December 2018)